Polyfluoroalkyl substances (PFAS) are man-made chemicals developed in the 1940s that have been used in consumer products and manufacturing processes worldwide ever since. Incredibly resistant, PFAS have been used to make water-repellent clothing, stain resistant fabrics, nonstick cookware and cosmetics, but also in the production of mRNA vaccines and semiconductors. Their very resistance however means they do not break down naturally and remain in the environment forever and, most concerning, can accumulate in living organisms leading to harmful health effects in humans such as increased risk of cancer, high cholesterol levels and changes in liver enzymes. In this interview Henrik Hagemann tells us how Puraffinity is tackling the PFAS crisis.

Henrik Hagemann
CEO and Co-Founder, Puraffinity

Henrik Hagemann is CEO and Co-Founder of Puraffinity. A Verve Ventures portfolio company since 2019, Puraffinity develops engineered biomaterials that target Polyfluoroalkyl substances (PFAS) in contaminated water. In 2019, Henrik was on Forbes’ 30 Under 30 Europe list and MIT Tech Review’s 35 Under 35 Europe list. He has been part of the Diversity and Inclusion Steering group at the Royal Academy of Engineering for the last five years and together with co-founder Gabriella Santosa, strives to build Puraffinity into a startup with equity, diversity and inclusion at its heart. Henrik has a master’s in biomedical engineering from Imperial College London where he was an honoree of the President’s Medal for Outstanding Achievement.

The deep-tech VC of choice for entrepreneurial investors

Since 2010, we have invested in 180 European deep tech companies based on topical experience. With a highly skilled team of investment professionals, we back outstanding entrepreneurs driving growth in key industries. Verve is the pioneer of deep tech in Europe.

Written by

WITH US, YOU CANCO-INVEST IN DEEP TECH STARTUPS

Verve's investor network

With annual investments of EUR 60-70 mio, we belong to the top 10% most active startup investors in Europe. We therefore get you into competitive financing rounds alongside other world-class venture capital funds.

We empower you to build your individual portfolio.

Sign up to receive our regular newsletter and learn about investing in technologies that are changing the world.

Privacy Preference Center